Global Myasthenia Gravis Market Growth (Status and Outlook) 2022-2028
- LP 4927647
- 102 Pages
- March 2022
- Medical Devices
The United States Myasthenia Gravis market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Myasthenia Gravis market, reaching US$ million by the year 2028. As for the Europe Myasthenia Gravis landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Myasthenia Gravis players cover Takeda, F. Hoffmann-La Roche, CSL Behring, and Grifols, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Myasthenia Gravis market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Drug Treatment
Rapid Immunotherapies
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospitals
Clinics
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Takeda
F. Hoffmann-La Roche
CSL Behring
Grifols
Alexion Pharmaceutical
Avadel Pharmaceuticals
Baxter International
Novartis
Bausch Health
Takeda Pharmaceutical Company
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Myasthenia Gravis Market Size 2017-2028
2.1.2 Myasthenia Gravis Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Myasthenia Gravis Segment by Type
2.2.1 Drug Treatment
2.2.2 Rapid Immunotherapies
2.3 Myasthenia Gravis Market Size by Type
2.3.1 Myasthenia Gravis Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Myasthenia Gravis Market Size Market Share by Type (2017-2022)
2.4 Myasthenia Gravis Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Other
2.5 Myasthenia Gravis Market Size by Application
2.5.1 Myasthenia Gravis Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Myasthenia Gravis Market Size Market Share by Application (2017-2022)
3 Myasthenia Gravis Market Size by Player
3.1 Myasthenia Gravis Market Size Market Share by Players
3.1.1 Global Myasthenia Gravis Revenue by Players (2020-2022)
3.1.2 Global Myasthenia Gravis Revenue Market Share by Players (2020-2022)
3.2 Global Myasthenia Gravis Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Myasthenia Gravis by Regions
4.1 Myasthenia Gravis Market Size by Regions (2017-2022)
4.2 Americas Myasthenia Gravis Market Size Growth (2017-2022)
4.3 APAC Myasthenia Gravis Market Size Growth (2017-2022)
4.4 Europe Myasthenia Gravis Market Size Growth (2017-2022)
4.5 Middle East & Africa Myasthenia Gravis Market Size Growth (2017-2022)
5 Americas
5.1 Americas Myasthenia Gravis Market Size by Country (2017-2022)
5.2 Americas Myasthenia Gravis Market Size by Type (2017-2022)
5.3 Americas Myasthenia Gravis Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Myasthenia Gravis Market Size by Region (2017-2022)
6.2 APAC Myasthenia Gravis Market Size by Type (2017-2022)
6.3 APAC Myasthenia Gravis Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Myasthenia Gravis by Country (2017-2022)
7.2 Europe Myasthenia Gravis Market Size by Type (2017-2022)
7.3 Europe Myasthenia Gravis Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Myasthenia Gravis by Region (2017-2022)
8.2 Middle East & Africa Myasthenia Gravis Market Size by Type (2017-2022)
8.3 Middle East & Africa Myasthenia Gravis Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Myasthenia Gravis Market Forecast
10.1 Global Myasthenia Gravis Forecast by Regions (2023-2028)
10.1.1 Global Myasthenia Gravis Forecast by Regions (2023-2028)
10.1.2 Americas Myasthenia Gravis Forecast
10.1.3 APAC Myasthenia Gravis Forecast
10.1.4 Europe Myasthenia Gravis Forecast
10.1.5 Middle East & Africa Myasthenia Gravis Forecast
10.2 Americas Myasthenia Gravis Forecast by Country (2023-2028)
10.2.1 United States Myasthenia Gravis Market Forecast
10.2.2 Canada Myasthenia Gravis Market Forecast
10.2.3 Mexico Myasthenia Gravis Market Forecast
10.2.4 Brazil Myasthenia Gravis Market Forecast
10.3 APAC Myasthenia Gravis Forecast by Region (2023-2028)
10.3.1 China Myasthenia Gravis Market Forecast
10.3.2 Japan Myasthenia Gravis Market Forecast
10.3.3 Korea Myasthenia Gravis Market Forecast
10.3.4 Southeast Asia Myasthenia Gravis Market Forecast
10.3.5 India Myasthenia Gravis Market Forecast
10.3.6 Australia Myasthenia Gravis Market Forecast
10.4 Europe Myasthenia Gravis Forecast by Country (2023-2028)
10.4.1 Germany Myasthenia Gravis Market Forecast
10.4.2 France Myasthenia Gravis Market Forecast
10.4.3 UK Myasthenia Gravis Market Forecast
10.4.4 Italy Myasthenia Gravis Market Forecast
10.4.5 Russia Myasthenia Gravis Market Forecast
10.5 Middle East & Africa Myasthenia Gravis Forecast by Region (2023-2028)
10.5.1 Egypt Myasthenia Gravis Market Forecast
10.5.2 South Africa Myasthenia Gravis Market Forecast
10.5.3 Israel Myasthenia Gravis Market Forecast
10.5.4 Turkey Myasthenia Gravis Market Forecast
10.5.5 GCC Countries Myasthenia Gravis Market Forecast
10.6 Global Myasthenia Gravis Forecast by Type (2023-2028)
10.7 Global Myasthenia Gravis Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Takeda
11.1.1 Takeda Company Information
11.1.2 Takeda Myasthenia Gravis Product Offered
11.1.3 Takeda Myasthenia Gravis Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Takeda Main Business Overview
11.1.5 Takeda Latest Developments
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Company Information
11.2.2 F. Hoffmann-La Roche Myasthenia Gravis Product Offered
11.2.3 F. Hoffmann-La Roche Myasthenia Gravis Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 F. Hoffmann-La Roche Main Business Overview
11.2.5 F. Hoffmann-La Roche Latest Developments
11.3 CSL Behring
11.3.1 CSL Behring Company Information
11.3.2 CSL Behring Myasthenia Gravis Product Offered
11.3.3 CSL Behring Myasthenia Gravis Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 CSL Behring Main Business Overview
11.3.5 CSL Behring Latest Developments
11.4 Grifols
11.4.1 Grifols Company Information
11.4.2 Grifols Myasthenia Gravis Product Offered
11.4.3 Grifols Myasthenia Gravis Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Grifols Main Business Overview
11.4.5 Grifols Latest Developments
11.5 Alexion Pharmaceutical
11.5.1 Alexion Pharmaceutical Company Information
11.5.2 Alexion Pharmaceutical Myasthenia Gravis Product Offered
11.5.3 Alexion Pharmaceutical Myasthenia Gravis Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Alexion Pharmaceutical Main Business Overview
11.5.5 Alexion Pharmaceutical Latest Developments
11.6 Avadel Pharmaceuticals
11.6.1 Avadel Pharmaceuticals Company Information
11.6.2 Avadel Pharmaceuticals Myasthenia Gravis Product Offered
11.6.3 Avadel Pharmaceuticals Myasthenia Gravis Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Avadel Pharmaceuticals Main Business Overview
11.6.5 Avadel Pharmaceuticals Latest Developments
11.7 Baxter International
11.7.1 Baxter International Company Information
11.7.2 Baxter International Myasthenia Gravis Product Offered
11.7.3 Baxter International Myasthenia Gravis Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Baxter International Main Business Overview
11.7.5 Baxter International Latest Developments
11.8 Novartis
11.8.1 Novartis Company Information
11.8.2 Novartis Myasthenia Gravis Product Offered
11.8.3 Novartis Myasthenia Gravis Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Novartis Main Business Overview
11.8.5 Novartis Latest Developments
11.9 Bausch Health
11.9.1 Bausch Health Company Information
11.9.2 Bausch Health Myasthenia Gravis Product Offered
11.9.3 Bausch Health Myasthenia Gravis Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Bausch Health Main Business Overview
11.9.5 Bausch Health Latest Developments
11.10 Takeda Pharmaceutical Company
11.10.1 Takeda Pharmaceutical Company Company Information
11.10.2 Takeda Pharmaceutical Company Myasthenia Gravis Product Offered
11.10.3 Takeda Pharmaceutical Company Myasthenia Gravis Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Takeda Pharmaceutical Company Main Business Overview
11.10.5 Takeda Pharmaceutical Company Latest Developments
12 Research Findings and Conclusion
Table 1. Myasthenia Gravis Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Drug Treatment
Table 3. Major Players of Rapid Immunotherapies
Table 4. Myasthenia Gravis Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Myasthenia Gravis Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Myasthenia Gravis Market Size Market Share by Type (2017-2022)
Table 7. Myasthenia Gravis Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Myasthenia Gravis Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Myasthenia Gravis Market Size Market Share by Application (2017-2022)
Table 10. Global Myasthenia Gravis Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Myasthenia Gravis Revenue Market Share by Player (2020-2022)
Table 12. Myasthenia Gravis Key Players Head office and Products Offered
Table 13. Myasthenia Gravis Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Myasthenia Gravis Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Myasthenia Gravis Market Size Market Share by Regions (2017-2022)
Table 18. Americas Myasthenia Gravis Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Myasthenia Gravis Market Size Market Share by Country (2017-2022)
Table 20. Americas Myasthenia Gravis Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Myasthenia Gravis Market Size Market Share by Type (2017-2022)
Table 22. Americas Myasthenia Gravis Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Myasthenia Gravis Market Size Market Share by Application (2017-2022)
Table 24. APAC Myasthenia Gravis Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Myasthenia Gravis Market Size Market Share by Region (2017-2022)
Table 26. APAC Myasthenia Gravis Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Myasthenia Gravis Market Size Market Share by Type (2017-2022)
Table 28. APAC Myasthenia Gravis Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Myasthenia Gravis Market Size Market Share by Application (2017-2022)
Table 30. Europe Myasthenia Gravis Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Myasthenia Gravis Market Size Market Share by Country (2017-2022)
Table 32. Europe Myasthenia Gravis Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Myasthenia Gravis Market Size Market Share by Type (2017-2022)
Table 34. Europe Myasthenia Gravis Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Myasthenia Gravis Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Myasthenia Gravis Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Myasthenia Gravis Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Myasthenia Gravis Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Myasthenia Gravis Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Myasthenia Gravis Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Myasthenia Gravis Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Myasthenia Gravis
Table 43. Key Market Challenges & Risks of Myasthenia Gravis
Table 44. Key Industry Trends of Myasthenia Gravis
Table 45. Global Myasthenia Gravis Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Myasthenia Gravis Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Myasthenia Gravis Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Myasthenia Gravis Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Myasthenia Gravis Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Myasthenia Gravis Market Size Market Share Forecast by Application (2023-2028)
Table 51. Takeda Details, Company Type, Myasthenia Gravis Area Served and Its Competitors
Table 52. Takeda Myasthenia Gravis Product Offered
Table 53. Takeda Myasthenia Gravis Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Takeda Main Business
Table 55. Takeda Latest Developments
Table 56. F. Hoffmann-La Roche Details, Company Type, Myasthenia Gravis Area Served and Its Competitors
Table 57. F. Hoffmann-La Roche Myasthenia Gravis Product Offered
Table 58. F. Hoffmann-La Roche Main Business
Table 59. F. Hoffmann-La Roche Myasthenia Gravis Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. F. Hoffmann-La Roche Latest Developments
Table 61. CSL Behring Details, Company Type, Myasthenia Gravis Area Served and Its Competitors
Table 62. CSL Behring Myasthenia Gravis Product Offered
Table 63. CSL Behring Main Business
Table 64. CSL Behring Myasthenia Gravis Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. CSL Behring Latest Developments
Table 66. Grifols Details, Company Type, Myasthenia Gravis Area Served and Its Competitors
Table 67. Grifols Myasthenia Gravis Product Offered
Table 68. Grifols Main Business
Table 69. Grifols Myasthenia Gravis Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Grifols Latest Developments
Table 71. Alexion Pharmaceutical Details, Company Type, Myasthenia Gravis Area Served and Its Competitors
Table 72. Alexion Pharmaceutical Myasthenia Gravis Product Offered
Table 73. Alexion Pharmaceutical Main Business
Table 74. Alexion Pharmaceutical Myasthenia Gravis Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Alexion Pharmaceutical Latest Developments
Table 76. Avadel Pharmaceuticals Details, Company Type, Myasthenia Gravis Area Served and Its Competitors
Table 77. Avadel Pharmaceuticals Myasthenia Gravis Product Offered
Table 78. Avadel Pharmaceuticals Main Business
Table 79. Avadel Pharmaceuticals Myasthenia Gravis Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Avadel Pharmaceuticals Latest Developments
Table 81. Baxter International Details, Company Type, Myasthenia Gravis Area Served and Its Competitors
Table 82. Baxter International Myasthenia Gravis Product Offered
Table 83. Baxter International Main Business
Table 84. Baxter International Myasthenia Gravis Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Baxter International Latest Developments
Table 86. Novartis Details, Company Type, Myasthenia Gravis Area Served and Its Competitors
Table 87. Novartis Myasthenia Gravis Product Offered
Table 88. Novartis Main Business
Table 89. Novartis Myasthenia Gravis Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. Novartis Latest Developments
Table 91. Bausch Health Details, Company Type, Myasthenia Gravis Area Served and Its Competitors
Table 92. Bausch Health Myasthenia Gravis Product Offered
Table 93. Bausch Health Main Business
Table 94. Bausch Health Myasthenia Gravis Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. Bausch Health Latest Developments
Table 96. Takeda Pharmaceutical Company Details, Company Type, Myasthenia Gravis Area Served and Its Competitors
Table 97. Takeda Pharmaceutical Company Myasthenia Gravis Product Offered
Table 98. Takeda Pharmaceutical Company Main Business
Table 99. Takeda Pharmaceutical Company Myasthenia Gravis Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. Takeda Pharmaceutical Company Latest Developments
List of Figures
Figure 1. Myasthenia Gravis Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Myasthenia Gravis Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Myasthenia Gravis Market Size Market Share by Type in 2021
Figure 7. Myasthenia Gravis in Hospitals
Figure 8. Global Myasthenia Gravis Market: Hospitals (2017-2022) & ($ Millions)
Figure 9. Myasthenia Gravis in Clinics
Figure 10. Global Myasthenia Gravis Market: Clinics (2017-2022) & ($ Millions)
Figure 11. Myasthenia Gravis in Other
Figure 12. Global Myasthenia Gravis Market: Other (2017-2022) & ($ Millions)
Figure 13. Global Myasthenia Gravis Market Size Market Share by Application in 2021
Figure 14. Global Myasthenia Gravis Revenue Market Share by Player in 2021
Figure 15. Global Myasthenia Gravis Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Myasthenia Gravis Market Size 2017-2022 ($ Millions)
Figure 17. APAC Myasthenia Gravis Market Size 2017-2022 ($ Millions)
Figure 18. Europe Myasthenia Gravis Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Myasthenia Gravis Market Size 2017-2022 ($ Millions)
Figure 20. Americas Myasthenia Gravis Value Market Share by Country in 2021
Figure 21. Americas Myasthenia Gravis Consumption Market Share by Type in 2021
Figure 22. Americas Myasthenia Gravis Market Size Market Share by Application in 2021
Figure 23. United States Myasthenia Gravis Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Myasthenia Gravis Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Myasthenia Gravis Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Myasthenia Gravis Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Myasthenia Gravis Market Size Market Share by Region in 2021
Figure 28. APAC Myasthenia Gravis Market Size Market Share by Application in 2021
Figure 29. China Myasthenia Gravis Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Myasthenia Gravis Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Myasthenia Gravis Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Myasthenia Gravis Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Myasthenia Gravis Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Myasthenia Gravis Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Myasthenia Gravis Market Size Market Share by Country in 2021
Figure 36. Europe Myasthenia Gravis Market Size Market Share by Type in 2021
Figure 37. Europe Myasthenia Gravis Market Size Market Share by Application in 2021
Figure 38. Germany Myasthenia Gravis Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Myasthenia Gravis Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Myasthenia Gravis Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Myasthenia Gravis Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Myasthenia Gravis Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Myasthenia Gravis Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Myasthenia Gravis Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Myasthenia Gravis Market Size Market Share by Application in 2021
Figure 46. Egypt Myasthenia Gravis Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Myasthenia Gravis Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Myasthenia Gravis Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Myasthenia Gravis Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Myasthenia Gravis Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Myasthenia Gravis Market Size 2023-2028 ($ Millions)
Figure 52. APAC Myasthenia Gravis Market Size 2023-2028 ($ Millions)
Figure 53. Europe Myasthenia Gravis Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Myasthenia Gravis Market Size 2023-2028 ($ Millions)
Figure 55. United States Myasthenia Gravis Market Size 2023-2028 ($ Millions)
Figure 56. Canada Myasthenia Gravis Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Myasthenia Gravis Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Myasthenia Gravis Market Size 2023-2028 ($ Millions)
Figure 59. China Myasthenia Gravis Market Size 2023-2028 ($ Millions)
Figure 60. Japan Myasthenia Gravis Market Size 2023-2028 ($ Millions)
Figure 61. Korea Myasthenia Gravis Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Myasthenia Gravis Market Size 2023-2028 ($ Millions)
Figure 63. India Myasthenia Gravis Market Size 2023-2028 ($ Millions)
Figure 64. Australia Myasthenia Gravis Market Size 2023-2028 ($ Millions)
Figure 65. Germany Myasthenia Gravis Market Size 2023-2028 ($ Millions)
Figure 66. France Myasthenia Gravis Market Size 2023-2028 ($ Millions)
Figure 67. UK Myasthenia Gravis Market Size 2023-2028 ($ Millions)
Figure 68. Italy Myasthenia Gravis Market Size 2023-2028 ($ Millions)
Figure 69. Russia Myasthenia Gravis Market Size 2023-2028 ($ Millions)
Figure 70. Spain Myasthenia Gravis Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Myasthenia Gravis Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Myasthenia Gravis Market Size 2023-2028 ($ Millions)
Figure 73. Israel Myasthenia Gravis Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Myasthenia Gravis Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Myasthenia Gravis Market Size 2023-2028 ($ Millions)
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
